课题基金 / 基金详情

Development of a nuclease-mediated technology to validate chromatin hubs

Development of a nuclease-mediated technology to validate chromatin hubs
开发核酸酶介导的技术来验证染色质中心
批准号:
8463009
负责人:
PEGGY J Farnham
金额:
$20.64万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-24 至 2015-03-31

项目摘要

项目成果

PEGGY J Farnham的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):尽管在绘制整个基因组中的转录因子结合位点方面已经取得了巨大的进展,并且继续扩大我们对转录因子的全局结合模式的了解是非常重要的,但是简单地收集全基因组数据集将不足以回答关于基因组生物学的所有关键问题。现在需要解决一些方法问题。特别是,我们必须开发新的方法来分析复杂的调控元件的功能。我们已经确定了基因组中被大量转录因子结合的区域,但不太可能是启动子区域,因为它们远离所有已知基因、预测基因、表达的RNA和H3 K4 me 3信号;我们将这些区域称为染色质枢纽。我们建议开发一种方法,通过该方法可以在其正常的基因组背景下进行调查的枢纽。大多数研究复杂调控元件功能的方法都涉及报告分析,无法揭示其对长程调控的影响。相比之下,我们的技术将基于锌指核酸酶(ZFN)和/或转录激活因子样效应物核酸酶(TALEN)对,其将允许精确缺失转录因子。 人类基因组的关键调控区域。从本质上讲,我们将开发一种方法,通过从人类基因组中特异性地删除一个复杂的元件来研究它,从而能够在天然基因组环境中分析一整套紧密排列的转录因子结合位点。我们的技术不仅对染色质枢纽的研究(如我们的提案中所述)非常宝贵,而且也适用于任何复杂调控区功能的“原位”表征。最近的基因组研究集中在记录表达的转录本和识别转录因子结合位点。基因组学的下一个阶段需要开发技术,使研究人员能够了解顺式调控区域如何影响转录组。我们的研究将有助于整合不同类型的基因组数据,并为基因组调控提供新的见解。
英文摘要
DESCRIPTION (provided by applicant): Although enormous progress has been made in mapping transcription factor binding sites throughout the genome and continuing to expand our knowledge of the global binding patterns of transcription factors is very important, simply collecting genome-wide datasets will not be sufficient to answer all crucial questions about genome biology. A number of methodological problems now need to be addressed. In particular, we must develop new methods for the functional analysis of complex regulatory elements. We have identified regions of the genome that are bound by a large number of transcription factors but are not likely to be promoter regions because they are located far from all known genes, predicted genes, expressed RNAs, and H3K4me3 signals; we have called these regions chromatin hubs. We propose to develop a method by which the hubs can be investigated in their normal genomic context. Most approaches designed to study the function of a complex regulatory element involve reporter analyses and cannot reveal effects on long-range regulation. In contrast, our technology will be based on pairs of zinc finger nucleases (ZFNs) and/or transcription activator-like effector nucleases (TALENs) that will allow precise deletion of critical regulatory regions of the human genome. In essence, we will develop an approach that will allow the study of a complex element by specifically deleting it from the human genome, thus enabling analysis of an entire set of closely packed transcription factor binding sites in ther natural genomic context. Our technology will not only be invaluable for the study of chromatin hubs (as described in our proposal) but will also be appropriate for an "in situ" characterization of the function of any complex regulatory region. Recent genomic research has focused on documenting expressed transcripts and identifying transcription factor binding sites. The next phase of genomics requires the development of technologies that will allow the investigator to understand how cis regulatory regions influence the transcriptome. Our studies will help to integrate different types of genomic data and provide new insights into genomic regulation.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cbpa.2015.10.001
发表时间: 2015-12
期刊: Current opinion in chemical biology
影响因子: 7.8
作者: [O'Geen H, Yu AS, Segal DJ]
通讯作者: Segal DJ
DOI: 10.1038/ncomms6114
发表时间: 2014-09-30
期刊: NATURE COMMUNICATIONS
影响因子: 16.6
作者: [Yao, Lijing, Tak, Yu Gyoung, Berman, Benjamin P., Farnham, Peggy J.]
通讯作者: Farnham, Peggy J.
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation.
人造锌指表观遗传调节剂的分析:广泛的结合但有限的调节。
DOI: 10.1093/nar/gku708
发表时间: 2014
期刊: Nucleic acids research
影响因子: 14.9
作者: [Grimmer MR, Stolzenburg S, Ford E, Lister R, Blancafort P, Farnham PJ]
通讯作者: Farnham PJ
DOI: 10.2217/epi.14.30
发表时间: 2014
期刊: Epigenomics
影响因子: 3.8
作者: [Grimmer MR, Farnham PJ]
通讯作者: Farnham PJ
Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
Characterization of a novel family of human transcription factors that bind at +240 downstream of the transcription start site.
Core-009
Core-009
海外基金